BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17241823)

  • 1. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
    Katayama H; Oda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction proteomics.
    Monti M; Orrù S; Pagnozzi D; Pucci P
    Biosci Rep; 2005; 25(1-2):45-56. PubMed ID: 16222419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic methods for drug target discovery.
    Sleno L; Emili A
    Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity chromatography: a useful tool in proteomics studies.
    Azarkan M; Huet J; Baeyens-Volant D; Looze Y; Vandenbussche G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):81-90. PubMed ID: 17113368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry.
    Kosaka T; Okuyama R; Sun W; Ogata T; Harada J; Araki K; Izumi M; Yoshida T; Okuno A; Fujiwara T; Ohsumi J; Ichikawa K
    Anal Chem; 2005 Apr; 77(7):2050-5. PubMed ID: 15801737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immuno-chemo-proteomics method for drug target deconvolution.
    Saxena C; Zhen E; Higgs RE; Hale JE
    J Proteome Res; 2008 Aug; 7(8):3490-7. PubMed ID: 18590316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.
    Annis DA; Nickbarg E; Yang X; Ziebell MR; Whitehurst CE
    Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific capture of uranyl protein targets by metal affinity chromatography.
    Basset C; Dedieu A; Guérin P; Quéméneur E; Meyer D; Vidaud C
    J Chromatogr A; 2008 Mar; 1185(2):233-40. PubMed ID: 18308325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific affinity extraction method for small molecule-binding proteins.
    Mano N; Sato K; Goto J
    Anal Chem; 2006 Jul; 78(13):4668-75. PubMed ID: 16808480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells.
    Bürckstümmer T; Bennett KL; Preradovic A; Schütze G; Hantschel O; Superti-Furga G; Bauch A
    Nat Methods; 2006 Dec; 3(12):1013-9. PubMed ID: 17060908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective ligand purification using high-performance affinity beads.
    Ohtsu Y; Ohba R; Imamura Y; Kobayashi M; Hatori H; Zenkoh T; Hatakeyama M; Manabe T; Hino M; Yamaguchi Y; Kataoka K; Kawaguchi H; Watanabe H; Handa H
    Anal Biochem; 2005 Mar; 338(2):245-52. PubMed ID: 15745744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target-based drug discovery: the emerging success of frontal affinity chromatography coupled to mass spectrometry.
    Calleri E; Temporini C; Caccialanza G; Massolini G
    ChemMedChem; 2009 Jun; 4(6):905-16. PubMed ID: 19378293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway proteomics and chemical proteomics team up in drug discovery.
    Hopf C; Bantscheff M; Drewes G
    Neurodegener Dis; 2007; 4(2-3):270-80. PubMed ID: 17596721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative chemical proteomics: simultaneous identification of disease-specific protein targets and their small molecule-binding partners, suitable as drug candidates].
    Dormán G; Puskás LG; Fehér LZ; Hackler L; Lorincz Z; Lang C; Urge L; Darvas F
    Acta Pharm Hung; 2006; 76(1):3-9. PubMed ID: 17094670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolving protein interactions and complexes by affinity purification followed by label-based quantitative mass spectrometry.
    Trinkle-Mulcahy L
    Proteomics; 2012 May; 12(10):1623-38. PubMed ID: 22610586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances and applications of de novo designed affinity ligands in proteomics.
    Roque AC; Lowe CR
    Biotechnol Adv; 2006; 24(1):17-26. PubMed ID: 16006085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates.
    Boersema PJ; Aye TT; van Veen TA; Heck AJ; Mohammed S
    Proteomics; 2008 Nov; 8(22):4624-32. PubMed ID: 18850632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revealing promiscuous drug-target interactions by chemical proteomics.
    Bantscheff M; Scholten A; Heck AJ
    Drug Discov Today; 2009 Nov; 14(21-22):1021-9. PubMed ID: 19596079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.